Deutsche Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Deutsche Bank’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-363,614	Closed	-$19.6M	–	5793
2017 Q4	$19.6M	Sell	363,614 -178,019	-33%	-$9.74M	0.01%	1027
2017 Q3	$30.9M	Buy	541,633 +210,044	+63%	+$12.3M	0.02%	773
2017 Q2	$19.9M	Sell	331,589 -175,070	-35%	-$9.97M	0.01%	949
2017 Q1	$27.6M	Buy	+506,659	New	+$25M	0.02%	739

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Deutsche Bank's BIVV Position: Q1 2018 in Review

Deutsche Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 363,614 shares — an estimated $19.6M sold.

Deutsche Bank first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $30.9M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Deutsche Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Deutsche Bank sold 363,614 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $19.6M.
Deutsche Bank first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Deutsche Bank's Bioverativ Inc. Common Stock position peaked at $30.9M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.